By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teikoku Pharma 

1718 Ringwood Avenue

San Jose  California  95131  U.S.A.
Phone: 408-501-1800 Fax: 408-501-1900



Drug Delivery

Company News
Eagle Pharma (EGRX), Teikoku Pharma Win FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation 12/28/2015 6:30:24 AM
Teikoku Pharma Announces Positive Study Results Of 7-Day Patch For Parkinson's Disease 12/2/2014 10:23:54 AM
Eisai Inc. (ESALF.PK) Amends License Agreement With Teikoku Pharma For Aricept(R) Patch (Donepezil Transdermal System) 4/20/2012 10:03:50 AM
Licensing Agreement for Pharmaceutical Disposal Technology Between Teikoku Pharma and Verde Environmental Technologies Inc. 9/15/2011 6:07:52 AM
Eisai Inc. (ESALF.PK) Aricept Patch for Alzheimer’s Isn’t Ready for Approval 4/25/2011 6:33:35 AM
Endo Pharmaceuticals (ENDP) Announces Receipt of Paragraph IV Certification Received by Teikoku Pharma from Mylan Technologies Inc. Advising Filing of ANDA 1/31/2011 10:44:26 AM
Teikoku Pharma: FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA for Review 9/20/2010 8:29:32 AM
Teikoku Pharma Acquires Travanti Pharma Inc. 5/8/2009 7:53:12 AM
Teikoku Pharma and Eisai Company, Ltd. (ESALY.PK) Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil 3/9/2009 12:05:48 PM
Dermatrends Announces Contract with Teikoku Pharma To Study Transdermal Application of Anti-Psychotic Drug 3/1/2007 2:53:26 PM